Author:
Johannesen Lars,Vicente Jose,Hosseini Meisam,Strauss David G.
Funder
U.S. Food and Drug Administration
Publisher
Public Library of Science (PLoS)
Reference39 articles.
1. Ventricular tachycardia with 2 variable opposing foci;F Dessertenne;Arch Mal Coeur Vaiss,1966
2. ICH. Guidance for industry E14 Clinical Evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs 2005 [cited 2016 February 16].
3. Dealing with global safety issues: was the response to QT-liability of non-cardiac drugs well coordinated?;N Stockbridge;Drug Saf,2013
4. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties;C Antzelevitch;Circulation,2004
5. Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone;L Wu;Cardiovasc Res,2008
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献